Clinical Trials Browser

Phase 1 × INDUSTRY × Part A and B: Advanced Solid Malignancies × Clear all

NCT02141347 2018-12-12

Ph1 to Assess Safety, Tolerability of Tremelimumab/ Tremelimumab+MEDI4736 in Japanese Solid Malignancies/ Mesothelioma

Phase 1 Completed

Other solid neoplasmThoracic

Part A and B: Advanced Solid Malignancies